The LXR agonist TO-901317, known for its potent induction of ABCA1, has previously been shown to enhance oligodendrocyte proliferation, differentiation, and maturation, and to alleviate ischemia and lysolecithin-induced demyelination [83, 84]. The gene discussed is ABCA1; the disease is ischemia.